Literature DB >> 16073432

Effect of human interferon preparations on lymphoblastogenesis in Down's syndrome.

C G Cupples1, Y H Tan.   

Abstract

The best characterised properties of human interferon, its antiviral (AV) and cell multiplication inhibitory (CMI) activities, are controlled, in an unexplained manner, by genes on chromosomes 21 (refs 1-4; 14-16). Human and animal interferons have various immunosuppressive effects, among them the inhibition in vitro of DNA synthesis in activated lymphocytes. Using mitogen- and antigen-stimulated lymphocytes from normal subjects (disomic 21) and others with Down's syndrome (trisomic 21), we have found that DNA synthesis is inhibited to a greater degree in the latter by both fibroblastoid and leukocyte interferons. We suggest that this property is also regulated by genes on chromosome 21.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16073432     DOI: 10.1038/267165a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  10 in total

1.  Immunity in Down's syndrome.

Authors:  R J Ablin
Journal:  Eur J Pediatr       Date:  1978-01-17       Impact factor: 3.183

2.  Cytogenetic analysis of the sensitivity to anti-viral and anti-cell growth activities of human fibroblast interferon in aneuploid human tumor cell lines. Brief report.

Authors:  A S Lubiniecki; V Jones; C Eatherly
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy.

Authors:  N Fujii; K Oguma; M Fujii; R Fukatsu; N Takahata; M Kitabatake
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

4.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

5.  Increased IFN-alpha-induced sensitivity but reduced reactivity of 2',5'-oligoadenylate synthetase (2,5AS) in trisomy 21 blood lymphocytes.

Authors:  A M Gerdes; M Hørder; V Bonnevie-Nielsen
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

6.  Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.

Authors:  Xiao-Fei Kong; Lisa Worley; Darawan Rinchai; Vincent Bondet; Puthen Veettil Jithesh; Marie Goulet; Emilie Nonnotte; Anne Sophie Rebillat; Martine Conte; Clotilde Mircher; Nicolas Gürtler; Luyan Liu; Mélanie Migaud; Mohammed Elanbari; Tanwir Habib; Cindy S Ma; Jacinta Bustamante; Laurent Abel; Aimé Ravel; Stanislas Lyonnet; Arnold Munnich; Darragh Duffy; Damien Chaussabel; Jean-Laurent Casanova; Stuart G Tangye; Stéphanie Boisson-Dupuis; Anne Puel
Journal:  J Clin Immunol       Date:  2020-06-22       Impact factor: 8.317

Review 7.  The interferons.

Authors:  J L Toy
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

8.  Mouse genes influence antiviral action of interferon in vivo.

Authors:  F Dandoy; J De Maeyer-Guignard; D Bailey; E De Maeyer
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes.

Authors:  Carmela Rita Balistreri; Claudia Leonarda Ammoscato; Letizia Scola; Tiziana Fragapane; Rosa Maria Giarratana; Domenico Lio; Maria Piccione
Journal:  Genes (Basel)       Date:  2020-11-28       Impact factor: 4.096

Review 10.  Down Syndrome and COVID-19: A Perfect Storm?

Authors:  Joaquin M Espinosa
Journal:  Cell Rep Med       Date:  2020-05-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.